1. Home
  2. Plans and Products
  3. Managed Care Plan
  4. Cancer
 

Cancer Treatment

The Managed Care Plan offers you access to an Oncology management programme to assist with the management of cancer. Registration is compulsory. Innovation drugs will incur a 20% co-payment once the Oncology Innovation Medicine limit of R781 500 is depleted.

How to register:

As soon as a cancer diagnosis is made, please forward your confirmation of diagnosis via email: oncology@angloms.co.za and call 0860 222 633 to register on the Oncology management programme

A consultant oncologist and a team of in-house medical staff at the Scheme's administrator constantly monitor new and innovative drugs for the treatment of cancer, manage the Oncology management programme and will work with your healthcare provider to ensure appropriate care.

Applications for chemotherapy are assessed in accordance with recognised treatment protocols. All drug therapies used for the side-effects of chemotherapy and pain relief need to be authorised. Once you have completed your course of chemotherapy, the Scheme will accept the post-chemotherapy or remission treatment plan. Remember to get your oncologist to register a post-treatment plan for you with the Scheme.

Pharmacy network:

The Pharmacy Designated Service Providers (DSPs) for approved oncology medicines administered in doctors' rooms include Dis-Chem Oncology Courier Pharmacy, Medipost Pharmacy, Olsens Pharmacy and Questmed. Medicines for in-room administration obtained from any other provider will incur a 20% co-payment.

For medicine scripted and dispensed at a retail pharmacy (including supportive medicines, oral chemotherapy, and hormonal therapy) are covered in full when dispensed at any MedXpress Network Pharmacy, such as Dis-Chem Oncology Courier Pharmacy, Medipost Pharmacy and Questmed. Medicines obtained from other retail pharmacies will be subject to a 20% co-payment.

Innovation medicine:

Funding is available for a defined list of innovative cancer medicines. The Scheme will fund at 100% of the Scheme Reimbursement Rate subject to the Oncology Innovation Benefit limit of R781 500. Once this limit has been reached, the Scheme will fund the treatment at 80% of the Scheme Reimbursement Rate and you will be responsible for the shortfall.

Treatments:

The programme covers a wide range of treatments and services, including chemotherapy, radiotherapy, hormonal therapy, consultations, blood tests, radiology, and more.

Hospital admissions:

Approved hospital admissions for surgery and chemotherapy or radiotherapy are funded according to your plan. Most medical expenses for surgery will be paid from the Risk Benefit and not your Oncology Benefit.

Bone marrow transplants:

The Scheme funds bone marrow donor searches and transplants up to the Scheme Reimbursement Rate.

Diagnosis tests:

All investigative tests related to pathology and radiology, prior to your diagnosis, will be paid from an unlimited benefit on the Managed Care Plan.

More information:

Information on the oncology benefits is available in the Oncology Management Programme information that you will receive on registration.
Oncology Benefit

Log in